OrbiMed For Profit

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Invests into

Investors

Industry: Longevity Biomarkers
Estimated Revenue: 13.7MWhat
Number Of Exists: 217
Headquarters: New York, New York, United States
Investor Type: Private Equity Firm
Employee Number: 101-250
Investment Stage: Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity
Founded Date: 1989-01-01
Register and Claim Ownership